Boston Scientific continues to expect Penumbra closing by year-end
Boston Scientific said it continues to expect its acquisition of Penumbra to close in the second half of 2026, subject to receipt of the remaining regulatory clearances. Boston Scientific executives reaffirmed...To view the full article, register now.
Already a subscriber? Click here to view full article